In-vivo studies have highlighted how SPP1− knockout mice have been shown to lead to decreased M0/M2 infiltration, a decrease in fibrosis, and exhibit positive results in OS59,60; despite these encouraging results, no current human clinical studies inhibiting SPP1 have been conducted on cancer. Here, SPP1 is linked to cancer.